Genetic testing must cope with biological complexity
The medication landscape is constantly changing, in particular the cancer medication landscape. A strong emphasis on cancer research has yielded
NextSeq 500: high-throughput desktop sequencer for clinical use
At the beginning of new year 2014 Illumina, Inc. presented two new instruments to its clients. First novelty is a NextSeq 500 desktop sequencer
NGS in clinical diagnostics, whole exome or targeted sequencing?
Next-generation sequencing is coming to clinical diagnostics, but which one is more suitable for clinicians, whole exome or targeted sequencing? The